Hôpital Robert Debré, APHP
Paris, 75019, France
NCT Number: NCT03371069
The use of methylphenidate in children and adolescents in France from 2010 to 2015
Looking for future studies?
Notify MeUp to 17 year
All sexes
Observational
Paris, 75019, France
To describe the use of methylphenidate in children and adolescents in France from 2010 to 2015
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Children and adolescents who are users of methylphenidate, 2010 to 2015
Time frame: 6 years
Describe of the use of methylphenidate over time to determine the impact of regulatory information of appropriate prescription conditions of use in September 2012
Time frame: 6 years
Pharmaceutical specialties (immediate or extended release forms) prescribed by type of delivery: initial or renewals.
Profile of prescribers: hospital or private practice (general practitioners, specialists) depending on type of prescription (initial or renewal); geographical distribution of the prescribers Profile of patients: sex, average age and age classes (0-23 months, 2-5 years, 6-11 years, 12-17 years), socioeconomic status, long-lasting diseases status for psychosis, severe personality disorder, mental retardation.
Pattern of methylphenidate use: duration of treatment, prolonged use, interruption of treatment.
Time frame: 6 years
Assistance Publique - Hôpitaux de Paris
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.